Information about Eptifibatide

Eptifibatide uses

Eptifibatide is used in the treatment of unstable angina.

How eptifibatide works

Eptifibatide prevents platelets from sticking together, which in turn lowers the formation of blood clots.

Common side effects of eptifibatide

Bleeding, Decreased blood pressure.

Available Medicine for Eptifibatide

  • ₹9618
    Abbott India Ltd
    1 variant(s)
  • ₹2500
    Lupin Ltd
    1 variant(s)
  • ₹2398 to ₹7950
    Cipla Ltd
    2 variant(s)
  • ₹2975 to ₹8372
    Sun Pharmaceutical Industries Ltd
    2 variant(s)
  • ₹10296
    Merck Ltd
    1 variant(s)
  • ₹2380 to ₹8500
    Torrent Pharmaceuticals Ltd
    2 variant(s)
  • ₹2471 to ₹8149
    Sun Pharmaceutical Industries Ltd
    2 variant(s)
  • ₹2657 to ₹8844
    Zydus Cadila
    2 variant(s)
  • ₹3000 to ₹10862
    Fulford India Ltd
    2 variant(s)

Expert advice for Eptifibatide

  • Eptifibatide may reduce the number of blood cells that are needed for clotting. Avoid situations where bruising or injury may occur. Report any unusual bleeding, bruising, blood in stools, or dark tarry stools to your doctor.
  • Before and during your treatment with eptifibatide samples of your blood will be tested as a safety measure to limit the possibility of unexpected bleeding.
  • Eptifibatide should be used with caution in the elderly, female patients and patients with low body weight because of the risk of bleeding.
  • Tell your doctor if you are using medicines to thin the blood (anticoagulants) such as warfarin, aspirin etc.
  • Talk to your doctor if you are pregnant or planning to become pregnant or are breastfeeding.
  • Consult your doctor if you are taking anticoagulants (e.g. warfarin, heparin, aspirin, and dipyridamole) or painkillers (e.g. ibuprofen) or thrombolytics (e.g. alteplase) because of increased risk of bleeding.

Frequently asked questions for Eptifibatide


Q. Is eptifibatide a thrombolytic agent/ what is eptifibatide infusion/ how does eptifibatide work?
Eptifibatide is a thrombolytic drug and belongs to a class of drugs called Glycoprotein IIb/IIIa inhibitors. It works by inhibiting platelet aggregation and thus prevents blockage of blood vessels due to formation of blood clots.

Content on this page was last updated on 10 May, 2017, by Dr. Varun Gupta (MD Pharmacology)